AAAAAA
Results: 1-25/100
Authors:
WIKSTRAND CJ
BIGNER DD
Citation: Cj. Wikstrand et Dd. Bigner, PROGNOSTIC APPLICATIONS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS LIGAND, TRANSFORMING GROWTH-FACTOR-ALPHA, Journal of the National Cancer Institute, 90(11), 1998, pp. 799-801
Authors:
WIKSTRAND CJ
REIST CJ
ARCHER GE
ZALUTSKY MR
BIGNER DD
Citation: Cj. Wikstrand et al., THE CLASS-III VARIANT OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII) - CHARACTERIZATION AND UTILIZATION AS AN IMMUNOTHERAPEUTIC TARGETS, Journal of neurovirology, 4(2), 1998, pp. 148-158
Authors:
LEE SE
JOHNSON SP
HALE LP
LI J
BULLOCK N
FUCHS H
FRIEDMAN A
MCLENDON R
BIGNER DD
MODRICH P
FRIEDMAN HS
Citation: Se. Lee et al., ANALYSIS OF DNA MISMATCH REPAIR PROTEINS IN HUMAN MEDULLOBLASTOMA, Clinical cancer research, 4(6), 1998, pp. 1415-1419
Authors:
REIST CJ
BIGNER DD
ZALUTSKY MR
Citation: Cj. Reist et al., HUMAN IGG2 CONSTANT-REGION ENHANCES IN-VIVO STABILITY OF ANTI-TENASCIN ANTIBODY 81C6 COMPARED WITH ITS MURINE PARENT, Clinical cancer research, 4(10), 1998, pp. 2495-2502
Authors:
BIGNER DD
BROWN MT
FRIEDMAN AH
COLEMAN RE
AKABANI G
FRIEDMAN HS
THORSTAD WL
MCLENDON RE
BIGNER SH
ZHAO XG
PEGRAM CN
WIKSTRAND CJ
HERNDON JE
VICK NA
PALEOLOGOS N
COKGOR I
PROVENZALE JM
ZALUTSKY MR
Citation: Dd. Bigner et al., IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS, Journal of clinical oncology, 16(6), 1998, pp. 2202-2212
Authors:
FRIEDMAN HS
KOKKINAKIS DM
PLUDA J
FRIEDMAN AH
COKGOR I
HAGLUND MM
ASHLEY DM
RICH J
DOLAN ME
PEGG AE
MOSCHEL RC
MCLENDON RE
KERBY T
HERNDON JE
BIGNER DD
SCHOLD SC
Citation: Hs. Friedman et al., PHASE-I TRIAL OF O-6-BENZYLGUANINE FOR PATIENTS UNDERGOING SURGERY FOR MALIGNANT GLIOMA, Journal of clinical oncology, 16(11), 1998, pp. 3570-3575
Authors:
HANLEY ML
ELION GB
COLVIN OM
MODRICH PL
KEIR S
ADAMS DJ
BIGNER DD
FRIEDMAN HS
Citation: Ml. Hanley et al., THERAPEUTIC EFFICACY OF VINORELBINE AGAINST PEDIATRIC AND ADULT CENTRAL-NERVOUS-SYSTEM TUMORS, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 479-482
Authors:
COGGINS CA
ELION GB
HOUGHTON PJ
HARE CB
KEIR S
COLVIN OM
BIGNER DD
FRIEDMAN HS
Citation: Ca. Coggins et al., ENHANCEMENT OF IRINOTECAN (CPT-11) ACTIVITY AGAINST CENTRAL-NERVOUS-SYSTEM TUMOR XENOGRAFTS BY ALKYLATING-AGENTS, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 485-490
Authors:
ASHLEY DM
SAMPSON JH
ARCHER GE
HALE LP
BIGNER DD
Citation: Dm. Ashley et al., LOCAL PRODUCTION OF TGF-BETA-1 INHIBITS CEREBRAL EDEMA, ENHANCES TNF-ALPHA INDUCED APOPTOSIS AND IMPROVES SURVIVAL IN A MURINE GLIOMA MODEL, Journal of neuroimmunology, 86(1), 1998, pp. 46-52
Authors:
REIST CJ
BIGNER DD
ZALUTSKY MR
Citation: Cj. Reist et al., HUMAN IGG(2) CONSTANT-REGION ENHANCES THE IN-VIVO STABILITY OF MONOCLONAL-ANTIBODY 81C6 COMPARED TO ITS MURINE PARENT, The Journal of nuclear medicine, 39(5), 1998, pp. 297-297
Authors:
FOULON CF
BIGNER DD
ZALUTSKY MR
Citation: Cf. Foulon et al., PRETARGETED RADIOIMMUNOTHERAPY USING ANTI-TENASCIN 81C6-STREPTAVIDIN CONJUGATES AND RADIOLABELED BIOTIN - PREPARATION OF REAGENTS, The Journal of nuclear medicine, 39(5), 1998, pp. 412-412
Authors:
COKGOR I
AKABANI G
BROWN MT
FRIEDMAN AH
COLEMAN RE
FRIEDMAN HS
THORSTAD WL
MCLENDON RE
BIGNER SH
ZHAO XG
PEGRAM CN
WIKSTRAND CJ
HERNDON JE
VICK NA
PALEOLOGOS N
ZALUTSKY MR
BIGNER DD
Citation: I. Cokgor et al., RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES, Neurology, 50(4), 1998, pp. 52005-52005
Authors:
MCLENDON RE
CLEVELAND L
PEGRAM C
BIGNER SH
BIGNER DD
FRIEDMAN HS
Citation: Re. Mclendon et al., IMMUNOHISTOCHEMICAL DETECTION OF THE DNA-REPAIR ENZYME O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN FORMALIN-FIXED, PARAFFIN-EMBEDDED ASTROCYTOMAS, Laboratory investigation, 78(5), 1998, pp. 643-644
Authors:
MATTHEWS MR
RASHEED BKA
MCLENDON RE
WIKSTRAND CJ
BIGNER DD
BIGNER SH
Citation: Mr. Matthews et al., MOLECULAR AND IMMUNOHISTOLOGIC (IHC) STUDIES ON OLIGODENDROGLIAL (O) TUMORS, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 16-16
Authors:
ASHLEY DM
KONG FM
BIGNER DD
HALE LP
Citation: Dm. Ashley et al., ENDOGENOUS EXPRESSION OF TRANSFORMING-GROWTH-FACTOR BETA-1 INHIBITS GROWTH AND TUMORIGENICITY AND ENHANCES FAS-MEDIATED APOPTOSIS IN A MURINE HIGH-GRADE GLIOMA MODEL, Cancer research, 58(2), 1998, pp. 302-309
Authors:
ARCHER GE
SAMPSON JH
BIGNER DD
Citation: Ge. Archer et al., VIRUSES AND ONCOGENES IN BRAIN-TUMORS, Journal of neurovirology, 3, 1997, pp. 76-77
Authors:
ASHLEY DM
BIGNER DD
Citation: Dm. Ashley et Dd. Bigner, RECENT ADVANCES IN THE BIOLOGY OF CENTRAL-NERVOUS-SYSTEM TUMORS, Current opinion in neurology, 10(6), 1997, pp. 445-451
Authors:
HAUCK ML
DEWHIRST MW
BIGNER DD
ZALUTSKY MR
Citation: Ml. Hauck et al., LOCAL HYPERTHERMIA IMPROVES UPTAKE OF A CHIMERIC MONOCLONAL-ANTIBODY IN A SUBCUTANEOUS XENOGRAFT MODEL, Clinical cancer research, 3(1), 1997, pp. 63-70
Authors:
REIST CJ
BATRA SK
PEGRAM CN
BIGNER DD
ZALUTSKY MR
Citation: Cj. Reist et al., IN-VITRO AND IN-VIVO BEHAVIOR OF RADIOLABELED CHIMERIC ANTI-EGFRVIII MONOCLONAL-ANTIBODY - COMPARISON WITH ITS MURINE PARENT, Nuclear medicine and biology, 24(7), 1997, pp. 639-647
Authors:
ZALUTSKY MR
STABIN MG
LARSEN RH
BIGNER DD
Citation: Mr. Zalutsky et al., TISSUE DISTRIBUTION AND RADIATION-DOSIMETRY OF ASTATINE-211-LABELED CHIMERIC 81C6, AN ALPHA-PARTICLE-EMITTING IMMUNOCONJUGATE, Nuclear medicine and biology, 24(3), 1997, pp. 255-261
Authors:
BEAN JM
ARCHER GE
MUNLEY MT
ONG E
SNYDER SA
HAROON ZA
MCLENDON RE
MARKS LB
STRATFORD MRL
CHAPLIN DJ
BRIZEL DM
BIGNER DD
DEWHIRST MW
Citation: Jm. Bean et al., THE IMPACT OF HYPOXIA AND OXYGENATION MODIFICATION ON THE RADIATION RESPONSE OF AN INTRACRANIAL RAT GLIOMA, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 247-247
Authors:
HARE CB
ELION GB
COLVIN OM
ALIOSMAN F
GRIFFITH OW
PETROS WP
KEIR S
MARCELLI SL
BIGNER DD
FRIEDMAN HS
Citation: Cb. Hare et al., CHARACTERIZATION OF THE MECHANISMS OF BUSULFAN RESISTANCE IN A HUMAN GLIOBLASTOMA-MULTIFORME XENOGRAFT, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 409-414
Authors:
KURPAD SN
DOLAN ME
MCLENDON RE
ARCHER GE
MOSCHEL RC
PEGG AE
BIGNER DD
FRIEDMAN HS
Citation: Sn. Kurpad et al., INTRAARTERIAL O-6-BENZYLGUANINE ENABLES THE SPECIFIC THERAPY OF NITROSOUREA-RESISTANT INTRACRANIAL HUMAN GLIOMA XENOGRAFTS IN ATHYMIC RATS WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 307-316
Authors:
MOYNIHAN K
ELION GB
PEGRAM C
REIST CJ
WELLNER D
BIGNER DD
GRIFFITH OW
FRIEDMAN HS
Citation: K. Moynihan et al., L-AMINO-ACID OXIDASE (LOX) MODULATION OF MELPHALAN ACTIVITY AGAINST INTRACRANIAL GLIOMA, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 179-186
Authors:
HARE CB
ELION GB
HOUGHTON PJ
HOUGHTON JA
MARCELLI SL
KEIR S
BIGNER DD
FRIEDMAN HS
Citation: Cb. Hare et al., THERAPEUTIC EFFICACY OF THE TOPOISOMERASE-I INHIBITOR PIPERIDINO]-1-PIPERIDINO)-CARBONYLOXY-CAMPTOTHECIN AGAINST PEDIATRIC AND ADULT CENTRAL-NERVOUS-SYSTEM TUMOR XENOGRAFTS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 187-191